InMed Pharmaceuticals (INM) Goodwill & Intangibles (2020 - 2026)

InMed Pharmaceuticals' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 9.79% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 9.79% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 44.64% from the prior year.
• Goodwill & Intangibles declined to $1.5 million in Q1 2026 per INM's latest filing, from $1.5 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $4.4 million in Q1 2022 and bottomed at $1.2 million in Q2 2023.
• The 5-year median for Goodwill & Intangibles is $1.7 million (2024), against an average of $2.1 million.
• Across the five-year window, Goodwill & Intangibles soared 152.15% in 2022 and plunged 64.07% in 2023, its largest moves.
• Year by year, Goodwill & Intangibles stood at $2.0 million in 2022, then soared by 44.43% to $2.9 million in 2023, then sank by 41.89% to $1.7 million in 2024, then declined by 9.56% to $1.5 million in 2025, then fell by 2.61% to $1.5 million in 2026.
• Per Business Quant, the three latest INM Goodwill & Intangibles figures stand at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025).